Chemours/$CC

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Chemours

The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.

Ticker

$CC
Sector

Primary listing

NYSE

Industry

Chemicals

Employees

6,000

ISIN

US1638511089

Chemours Metrics

BasicAdvanced
$1.9B
68.85
$0.18
1.61
$0.84
2.82%

What the Analysts think about Chemours

Analyst ratings (Buy, Hold, Sell) for Chemours stock.

Bulls say / Bears say

Chemours' Thermal & Specialized Solutions segment achieved record first-quarter results in 2023, driven by strong demand for Opteon™ low global warming potential refrigerants. (businesswire.com)
The company realized meaningful cost savings from its Titanium Technologies Transformation Plan, enhancing operational efficiency. (chemours.com)
Chemours made significant progress in resolving legacy environmental issues, potentially reducing future litigation risks. (chemours.com)
An internal review revealed that senior executives manipulated financial data in late 2023 to meet free cash flow targets linked to their incentives, leading to material weaknesses in financial controls. (reuters.com)
Chemours placed its CEO and CFO on administrative leave amid the financial review, causing a significant drop in share value. (reuters.com)
The company reported a net loss of $238 million for the full year 2023, down from a net income of $578 million in 2022, indicating financial instability. (reuters.com)
Data summarised monthly by Lightyear AI. Last updated on 7 Jul 2025.

Chemours Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Chemours Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CC

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs